The Europe Bionematicides Market was worth USD 38.75 million in 2021 and estimated to be growing at a CAGR of 17.70%, to reach USD 79.72 million by 2026.
Bionematicides, for the most part, contains fungal or bacterial spores and inert material. Spores incorporated into the bionematicide germinate and paralyze the living being in contact with it. It is accessible in fluid and powder form. The upsides of bionematicides incorporate no resistance advancement, no resurgence and no residues.
Europe Bionematicides Market Drivers:
Europe is expected to lead the bionematicides showcase during the forecast period. Factors, for example, integrated pest management methods, and an increased selection of agriculture microbials are driving the interest for bionematicides in this region. In addition, countries like Spain and France have agriculture as their significant part which impacts the GDP of the nation is another variable that drives the market for bionematicides in Europe.
Europe Bionematicides Market - By Type:
Europe Bionematicides Market - By Crop Type:
Europe Bionematicides Market - By Mode of Application:
Europe Bionematicides Market - By Infestation:
On the basis of geography, the Europe market is analysed under various regions namely
Some of the major companies dominating the bionematicides market, by their products and services includes Bayer CropScience AG, Monsanto Company, BASF SE, Certis USA L.L.C, Syngenta AG, FMC Corporation, Dow AgroSciences LLC, Valent BioSciences Corporation and Marrone Bio Innovations, Inc.,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com